Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Analyst Sentiment
Analysts are neutral — opinion is divided on direction.
Consensus Rating
Hold
5 analysts·Limited coverage
40%
Rating Distribution
Strong Buy
00%
Buy
240%
Hold
360%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Current price is 60% above analyst consensus — significant downside expected.
Bear Case
$0.50
-60%
Consensus
$0.50
-60%
Bull Case
$0.50
+-60%
Price Range5 analysts
Low
Consensus
High
$0.50
$0.50
Current Target
Current Price
$1.24
Above Target
$0.74
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.